The evolution of pharma customer engagement insight
Over the last three years, customer engagement in the pharmaceutical industry has evolved significantly. Despite the improvement in screen-to-screen (S2S) interactions since 2020, face-to-face (F2F) operations are still on the agenda for many pharma companies. To fully realize the potential of a fit-for-purpose engagement model, the following points should be considered:
- A blended engagement model
- Emotive, patient-centric selling
- Referencing previous HCP interactions
- Cross-functional account management
Putting this strategy into practice, a tailored engagement model can be made to achieve the best-selling outcome.
In the full article from STEM, an Inizio Advisory company, the evolution to a more integrated, hybrid and patient-centric engagement model is explored in more detail.
https://www.stemhealthcare.com/insights/the-evolution-of-pharma-customer-engagement/
Jump to a slide with the slide dots.
12 Questions with Remco op den Kelder
Remco op den Kelder shares his leadership path, AI insights & vision for patient-focused pharma strategy in this Q&A with pharmaphorum.
Read moreInside ASCO® 2025: What oncologists really want from booth strategy
Congress engagement is being redefined - driven by oncologists’ learning preferences, AI integration, sustainability mandates, and smart booth design.
Read moreHow smart spaces and real-time strategy transformed ASCO® 2025
From LED walls to real-time in-booth optimization, ASCO® 2025 uncovered how we should engage and evolve the congress experience.
Read more